Genzyme Corp (NASDAQ:GENZ.DL)

CAPS Rating: No stars

A biotechnology company dedicated to making an impact on the lives of people with serious diseases. Its product and service portfolio is focused on rare disorders, renal diseases, orthopaedics, organ transplant, and diagnostic and predictive testing.

GENZ.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top GENZ.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.80)
Submitted February 27, 2009

Just as Obama enthusiasm for stem cell stocks is senseless, Obama pessimism for pharmaceuticals is overblown. I don't believe his policies will fundamentally change the business model or profitability of mid-to-large cap biotechs, and I see this as… More

SatoRey (< 20)
Submitted August 17, 2009

My first concern is around the virus issues in their main manufacturing facility; these contaminations are very difficult to clean up and there are reasonable odds of a recurring event. Second, and more importantly, I have lost faith in their… More

GENZ.DL VS S&P 500 (SPY)

GENZ.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about GENZ.DL.

No one has written a Pitch for GENZ.DL stock yet. Tell us why you think GENZ.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in GENZ.DL.

No players have picked GENZ.DL yet. Tell us why you think GENZ.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackZacks < 20 10/8/2010 Outperform 3M $72.75 -1.18% +0.17% -1.35 10/19/2010 @ $71.89 1 Comment
TrackZacks < 20 7/21/2010 Underperform 3M $52.62 +28.07% -1.44% -29.51 8/24/2010 @ $67.39 1 Comment
TrackZacks < 20 5/24/2010 Underperform 3M $48.48 +9.34% -0.51% -9.85 7/8/2010 @ $53.01 1 Comment
TrackArgus 87.14 3/26/2010 Outperform NS $52.73 +28.58% -5.15% +33.73 7/28/2010 @ $67.80 0 Comment
trackhapoalim < 20 3/25/2010 Underperform NS $51.70 +5.59% +1.99% -3.60 4/21/2010 @ $54.59 0 Comment
TrackJPMorgan 87.87 3/25/2010 Underperform NS $53.89 -1.24% +1.00% +2.24 4/30/2010 @ $53.22 0 Comment
TrackCitigroup 92.73 12/1/2009 Outperform NS $51.62 +47.71% +21.36% +26.36 4/9/2011 @ $76.25 0 Comment
TrackIcahn 89.17 9/30/2009 Outperform NS $56.73 +34.41% +29.02% +5.39 4/9/2011 @ $76.25 0 Comment
TrackLeerinkSwan 95.68 8/21/2009 Outperform NS $53.41 +42.76% +30.51% +12.25 4/9/2011 @ $76.25 0 Comment
TrackZacks < 20 8/7/2009 Underperform 3M $48.19 +11.02% +13.26% +2.24 1/13/2010 @ $53.50 1 Comment
TrackPatDorsey < 20 6/26/2009 Outperform 5Y $56.50 +34.96% +44.66% -9.71 4/9/2011 @ $76.25 0 Comment
TrackRBCCapMkts 87.00 6/23/2009 Outperform NS $53.62 -7.50% +12.56% -20.06 8/5/2009 @ $49.60 0 Comment
TrackCollinsStew 74.38 4/14/2009 Outperform NS $55.04 -5.98% +31.26% -37.24 12/3/2009 @ $51.75 0 Comment
TrackPiperJaff 85.40 3/27/2009 Outperform NS $58.34 +30.70% +61.87% -31.17 4/9/2011 @ $76.25 0 Comment
TrackDeutscheSec 88.16 3/9/2009 Outperform NS $54.03 +41.13% +95.47% -54.34 4/9/2011 @ $76.25 0 Comment
TrackBarclaysCap 90.87 3/3/2009 Outperform NS $51.79 +47.23% +88.45% -41.22 4/9/2011 @ $76.25 0 Comment
TrackJefferies 79.19 2/12/2009 Outperform NS $70.28 +8.49% +61.73% -53.23 4/9/2011 @ $76.25 0 Comment
TrackMorganJos 81.72 1/6/2009 Outperform NS $68.44 +9.95% +42.63% -32.68 2/17/2011 @ $75.25 0 Comment
TrackBofASec 94.06 8/5/2008 Outperform NS $76.81 -0.73% +5.41% -6.14 4/9/2011 @ $76.25 0 Comment
TrackCitigroup 92.73 7/14/2008 Outperform NS $77.93 -31.14% -42.94% +11.79 3/3/2009 @ $53.66 0 Comment
TrackUBS 92.16 7/1/2008 Outperform NS $72.33 +5.42% +4.94% +0.48 4/9/2011 @ $76.25 0 Comment
TrackBernstein 90.96 5/14/2008 Outperform NS $69.53 +9.66% -5.77% +15.44 4/9/2011 @ $76.25 0 Comment
TrackLazardCapit 83.22 4/4/2008 Outperform NS $75.09 +1.54% -3.58% +5.12 4/9/2011 @ $76.25 0 Comment
TrackZacks < 20 12/17/2007 Outperform 3M $73.53 -9.21% -31.89% +22.68 10/20/2008 @ $66.76 1 Comment
TrackWellsFargo 86.56 10/11/2007 Outperform NS $70.00 +8.93% -15.34% +24.27 4/9/2011 @ $76.25 0 Comment
TrackEveillard 94.71 9/30/2007 Outperform NS $61.96 +23.06% -12.92% +35.99 4/9/2011 @ $76.25 1 Comment
TrackEdwardOwens 99.19 9/30/2007 Outperform NS $61.96 +23.06% -12.92% +35.99 4/9/2011 @ $76.25 4 Comments
TrackIcahn 89.17 9/30/2007 Outperform NS $61.96 +20.14% -4.17% +24.32 12/31/2007 @ $74.44 1 Comment
TrackFortisBank < 20 7/9/2007 Outperform NS $61.08 +27.87% -29.91% +57.77 10/2/2008 @ $78.10 0 Comment
TrackLehmanBros < 20 6/26/2007 Outperform NS $64.25 +18.68% -11.55% +30.23 4/9/2011 @ $76.25 0 Comment
TrackMatrix < 20 3/15/2007 Outperform NS $60.40 +26.24% -4.40% +30.64 4/9/2011 @ $76.25 0 Comment
TrackStifel 92.01 1/31/2007 Outperform NS $65.33 +16.72% -6.85% +23.57 4/9/2011 @ $76.25 0 Comment
TrackRWBaird 88.57 1/4/2007 Outperform NS $63.59 -15.32% -27.72% +12.41 8/31/2009 @ $53.85 0 Comment
TrackAGEdwards < 20 8/30/2006 Outperform NS $66.46 -3.11% +17.74% -20.85 6/1/2007 @ $64.39 0 Comment
TrackJimCramer 85.44 5/25/2006 Outperform 3W $58.50 +30.34% +3.49% +26.85 4/9/2011 @ $76.25 0 Comment

Featured Broker Partners